Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00061828 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
MinorPrimary and study completion dates: May 2029 to May 31, 2029v32
NotablePrimary and study completion dates: May 2024 to May 2029v31
Show 29 earlier versionsHide 29 earlier versions
MinorSite contacts updated at 4 of 16 sitesv30
MinorSite contacts updated at 1 of 16 sitesv29
MinorRe-verified, no change to tracked fieldsv28
MinorSite contacts updated at 10 of 16 sitesv27
MinorStart date: May 2004 to Apr 21, 2004v26
NotableTrial status: Suspended to Recruiting
Site details revised at 16 of 16 sites
v25
StoppedTrial status: Recruiting to SuspendedSponsor's reason: Study visits suspended due to COVID-19 pandemic.
Site details revised at 16 of 16 sites
v24
MinorEligibility criteria expanded, about 6 words
Study description expanded, about 13 words
Site contacts updated at 3 of 16 sites
v23
MinorSite contacts updated at 3 of 16 sitesv22
NotablePrimary and study completion dates: May 2019 to May 2024
Site contacts updated at 3 of 16 sites
v21
MinorStudy description shortened, about 12 words
Study sites revised (16)
Study title shortened, about 1 word
v20
MinorSite contacts updated at 2 of 16 sitesv19
NotableLead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Arbor Research Collaborative for Health
Site contacts updated at 8 of 16 sites
Collaborators expanded, about 10 words
Study title expanded, about 4 words
v18
MinorStudy sites: 15 to 16
Eligibility criteria expanded, about 147 words
Study description expanded, about 424 words
v17
MinorPrimary and study completion dates: May 2019
Study sites revised (15)
v16
NotableEnrollment target: 400 to 1000
Study sites: 14 to 15
v15
MinorStudy sites: 10 to 14v14
Minor6 versionsRe-verified since Jul 11, 2008, no change to tracked fieldsv8-v13
MinorSite contacts updated at 3 of 10 sitesv7
Minor2 versionsRe-verified since Dec 11, 2006, no change to tracked fieldsv5-v6
MinorStudy sites revised (10)v4
MinorStudy sites: 9 to 10
Start date: May 2004
v3
MinorRe-verified, no change to tracked fieldsv2
MinorStudy First Submitted
Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Biliary atresia, idiopathic neonatal hepatitis, and specific genetic cholestatic conditions are the most common causes of jaundice and hyperbilirubinemia that continue beyond the newborn period. The long term goal of the Childhood Liver Disease Research Network (ChiLDReN) is to establish a database of clinical information and plasma, serum, and tissue samples from cholestatic children to facilitate research and to perform clinical, epidemiological and therapeutic trials in these important pediatric liver diseases.